Apoptotic pathways in ischemic acute renal failure  by Kaushal, Gur P. et al.
500 Forefronts in Nephrology
Apoptotic pathways in ischemic acute renal failure
GUR P. KAUSHAL, ALEXEI G. BASNAKIAN, and SUDHIR V. SHAH
Department of Medicine, Division of Nephrology, University of Arkansas for Medical Sciences, Little Rock, Arkansas; and Central
Arkansas Veterans Healthcare System, Little Rock, Arkansas
Apoptotic pathways in ischemic acute renal failure. The study
of cell death has emerged as an important and exciting area of
research in cell biology. Although two kinds of cell death, apop-
tosis and necrosis, are recognized, one of the major advances
in our understanding of cell death has been the recognition
that the pathways traditionally associated with apoptosis may
be very critical in the form of cell injury associated with necro-
sis. Renal tubular epithelial cell injury from ischemia has been
generally regarded as a result of necrotic form of cell death.
We briefly describe recent evidence indicating that pathways
generally associated with apoptosis, including endonuclease ac-
tivation, role of mitochondria and caspases, are important in
renal tubular injury. It is likely that the cascades that lead to
apoptotic or necrotic mode of cell death are activated almost
simultaneously and may share some common pathways.
The modern study of cell death began with the land-
mark publication by Kerr, Wyllie, and Currie in 1972 [1],
in which they coined the term “apoptosis” and made a
distinction between necrosis and apoptosis based on mor-
phologic criteria. Thus, in necrosis there is swelling of cell
organelles, a loss of plasma membrane integrity and rup-
ture of cell, invoking an inflammatory response [1, 2].
In contrast, in apoptosis, cells shrink, lose microvilli and
cell junctions, and explode into a series of membrane-
bound condensed apoptotic bodies and affected cells are
phagocytized by adjutant viable cells with little leakage of
cellular contents, thus invoking no inflammation. Apop-
tosis has been shown to be important, for example, in
embryogenesis and normal tissue turnover in which it is
appropriate only because apoptosis evokes no inflamma-
tion [1, 2]. In contrast, accidental cell death which might
occur after severe insults such as ischemic or toxic injury is
generally assumed to result in a catastrophic breakdown
of regulated cellular homeostasis that is necrosis.
One of the major advances in our understanding of cell
death has been the recognition that the pathways tradi-
tionally associated with apoptosis may be very critical in
the form of cell injury associated with necrosis. Thus, it is
now recognized that the same insult may result in apop-
tosis or necrosis with the mild injury generally resulting
in apoptosis and severe injury in necrosis [3, 4]. Thus,
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the pathway that is followed by the cell is dependent on
both nature and severity of insults. It appears likely that
the cascades that lead to apoptotic and necrotic mode of
cell death are activated almost simultaneously and that
there are some common pathways which are shared and
regulated in the two modes of cell death [2].
DNA FRAGMENTATION AND
ENDONUCLEASES IN RENAL TUBULAR
EPITHELIAL CELL INJURY
There are several in vivo studies that have demon-
strated chromatin condensation, the morphologic hall-
mark of apoptosis, in models of acute renal failure (ARF),
including ischemia/reperfusion (I/R) injury. However,
much of the evidence for the role of apoptotic mech-
anisms in renal tubular epithelial cell injury relates to
the demonstration of endonuclease activation resulting
in oligonucleosome-length DNA fragmentation (approx-
imately 200 bp), which has been regarded as one of the
biochemical hallmarks of apoptosis. One of the first stud-
ies to describe this was by Schumer et al [5], in which
DNA fragmentation in the kidney cortex was detected
12 hours after reperfusion. Similarly, several studies us-
ing immunohistochemical techniques have reported the
typical ladder pattern of DNA after subjecting kidneys
to I/R [6–8]. Additional evidence for the importance of
apoptosis in I/R has been provided by recent studies by
Kelly et al [9, 10], who have demonstrated the importance
of guanosine triphosphate (GTP) depletion in apoptosis
(versus ATP in necrosis) and the ability of guanosine and
P53 inhibitors to protect against apoptosis and renal dys-
function.
Approximately 40 double-stranded DNA breaks per
cell have been shown to be lethal [11] because beyond
this level, the repair of DNA breaks is no longer effec-
tive. Thus, the 200 bp ladder, which is used because of
its simplicity, actually measures very late events and the
chromatin does not need to be cut to the 200 bp fragments
to induce cell death. The sensitivity of the method used to
measure DNA strand breaks determines to a great extent
the time point when the DNA fragmentation can be reg-
istered. Other methods, such as pulse-field electrophore-
sis and random oligonucleotide primed synthesis (ROPS)
assay, are aimed to quantify rare DNA breaks and provide
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more sensitive timing of DNA fragmentation. A key
question is whether or not endonuclease activation is
related to cell death. In addition, it is important to know if
the endonuclease activation and subsequent DNA frag-
mentation is at a point of no return so that any attempt
to halt this process would not prevent cell death.
Our own interest in the role of endonucleases in re-
nal tubular epithelial cell injury began with our attempts
to understand the biochemical and cellular mechanisms
of oxidant injury. It was generally accepted that hydro-
gen peroxide gets to the DNA and in the presence of
iron in the DNA results in the site-specific generation
of hydroxyl radical which causes the DNA damage. We
were able to show that, in hydrogen peroxide–induced
injury to renal tubular epthelial cells, endonuclease acti-
vation occurs as an early event leading to DNA fragmen-
tation and that endonuclease inhibitors prevent hydrogen
peroxide–induced DNA strand breaks, DNA fragmenta-
tion, and cell death [12]. Based on the demonstration of
the role of endonucleases in oxidant injury, we surmised
that endonuclease activation may be important in those
forms of acute renal tubular injury where reactive oxygen
metabolites have been implicated [13].
Our data led us to consider whether endonuclease ac-
tivation may be important in hypoxia/reoxygenation in-
jury, generally considered to lead to necrotic form of
cell death. We demonstrated that hypoxia/reoxygenation
to freshly isolated rat proximal tubules results in DNA
strand breaks and nuclear DNA fragmentation which
precedes cell death [14]. Hypoxia/reoxygenation resulted
in an increase in DNA-degrading activity with an appar-
ent molecular mass of 15 kD. Endonuclease inhibitors
provided complete protection against DNA damage in-
duced by hypoxia/reoxygenation and partial but signifi-
cant protection against cell death. We have also shown
the role of endonuclease in a model of chemical hypoxia
[15]. Taken together, our data provide strong evidence
for a role of endonuclease activation in DNA damage
and cell death in hypoxia/reoxygenation injury.
It is important to note that despite unequivocal evi-
dence of endonuclease activation, the morphologic fea-
tures of apoptosis, including chromatin condensation,
were not observed by light and electron microscopy [14].
This is consistent with recent studies indicating that chro-
matin condensation and DNA fragmentation may be
triggered through separate metabolic pathways [14]. Im-
portantly, necrosis often shares some features of apop-
tosis, and the 200 bp ladder is one of them [7, 14]. The
observation that necrosis produces a “smear” instead of
the ladder most likely depends on the activity of cellu-
lar proteinases sufficient to remove histones from the
DNA.
The important point is that regardless of whether the
cells have morphologic features of apoptosis or necro-
sis, the endonucleases appear to be important as de-
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Fig. 1. Antisense DNA inhibition of hypoxia/reoxygenation-induced
DNA fragmentation and cell death in renal tubular cells. Cells were elec-
troporated with DNase I antisense oligodeoxynucleotide. Cell death
was measured by trypan blue exclusion, and DNA strand breaks were
quantified with the ROPS assay. Each point is mean ± SEM (N = 4).
∗P < 0.05, significantly different from control value (J Am Soc Nephrol
13:1000–10007, 2002, permission requested).
scribed above. Multiple studies by several groups have
shown a direct link between endonuclease-generated
DNA breaks and subsequent cell death in different sys-
tems [16–20]. In addition, there is also direct evidence
that overexpression of DNase I [19], DNase II [17], and
caspase-activated DNase [16] cause DNA fragmentation
and irreversible cell death. Acting alone, each of these
DNases is capable of causing cell death. On the other
hand, it should be recognized that a significant portion
of DNA breaks occurs after cell death as a part of the
“clean-up” of the debris of dead cells.
Endonucleases in the kidney
Limited information is available regarding the endonu-
clease(s) responsible for the DNA fragmentation in the
kidney. Our studies showed the presence of two major
endonucleases in kidneys and kidney cells, 15 kD en-
donuclease mentioned above and 30 to 34 kD DNase
I-like endonuclease [12, 14, 15, 21]. The 30 kD is mainly a
cytoplasmic enzyme, whereas the 15 kD endonuclease is
located in the nuclei. This enzyme was similar to a DNase
I by its biochemical characteristics. DNase I is found in
all studied species and tissues [22] and is expressed prin-
cipally in tissues of the digestive system [23]. In nondi-
gestive tissues (including kidney), the role of DNase I
is not known. Among various organs and tissues, the
kidney has one of the highest levels of DNase I activ-
ity as measured using DNA-substrate gel electrophoresis
[22, 23]. In our study we have begun to examine the
role of DNase I in renal injury. The activity of 30 kD
endonuclease is increased during I/R in rat kidney [21].
The role of DNase I in hypoxia/reoxygenation injury was
demonstrated in an in vitro study where renal tubular
502 Forefronts in Nephrology
Htr/OMI
Smac/
Diablo
IAPS
Serine
protease
activity Other
substrates
Caspase-3
Caspase-9
CytC
Bcl-2
+ APAF1 + dATP
+ Procaspase-9
ICAD
CAD CAD
Cell death
DNA fragmentation
Nucleus
AIF
PARP
NAD+
depletion
Caspase-2
Endo G
Fig. 2. Mitochondrial-mediated caspase-dependent and caspase-
independent pathways of cell death.
epithelial cells transfected with phosphorothioated
DNase I antisense oligonucleotides were protected
against DNA damage and cell death (Fig. 1) [21].
Among other endonucleases available for DNA frag-
mentation in the kidney, DNase gamma, DNase II and
caspase-activated have been described [16, 19, 24]. A
caspase-activated DNase of 40 kD, an apoptotic endonu-
clease, has been identified by Enari et al [16] in the cy-
toplasmic fraction. This enzyme is present in mouse and
human kidney, whereas some other tissues were found to
be caspase-activated DNase negative [25].
MITOCHONDRIA: ARMED AND LETHAL
Although the paper by Kerr, Wyllie, and Currie [1],
which stated that several organelles like mitochondria
did not undergo major modifications during apoptosis,
recent evidence suggests that mitochondria act as central
coordinators of the downstream execution phase of cell
death (Fig. 2) [26–29]. Several proapoptotic signal trans-
duction and damage pathways converge on mitochondria
to induce mitochondrial membrane permeabilization and
this phenomenon is under the control of Bcl-2–related
proteins. The inner membrane is characterized by a trans-
membrane potential w m generated through the activity
of proton pumps of the respiratory chain. w m dissipates
after the cells are induced to die. The outer mitochondrial
member becomes completely permeabilized to proteins,
resulting in the leakage of potentially toxic mitochondrial
intermembrane proteins that orchestrate the degradation
phase of cell death.
The notion that a specific class of proteases, the “cas-
pases” (cysteine aspartate-specific proteases), are in-
volved in apoptosis, emerged from genetic studies of the
nematode Caenorrhabditis elegans which revealed that
131 cells out of 1093 die during the development of the
worm and that a specific set of genes are required for this
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Fig. 3. Phosphatidylinositol 3′ (PI-3) kinase-Akt phosphorylation
pathway that regulates caspase-9 and caspase-3 activation.
process to occur. Caspases are a family of structurally
related cysteine proteases that play a central role in the
execution of apoptosis [30–32]. On receiving a proapop-
totic stimulus, the caspases are proteolytically processed
to the active forms from their normally synthesized inac-
tive proenzymes. At least 14 caspases encoded by dis-
tinct genes have been cloned and sequenced to date
in mammals [31]. Caspase-2, -8, -9, and -10 have large
prodomains and initiate the activation of downstream
caspases. Caspase-3, -6, and -7 with smaller domains are
identified as effecter or executioner caspases [30–32].
The executioner caspases are the major active caspases
detected in apoptotic cells and are widely regarded to
mediate the execution of apoptosis by cleaving and inac-
tivating intracellular proteins that are essential for cell
survival and proliferation [30–33]. The specificity of
downstream executioner caspases to cleave cellular pro-
teins is unique because of their different primary se-
quences and different recognition sites on the target
proteins. For example, following activation, caspase-3
primarily recognizes Asp-Glu-Val-Asp (DEVD) or Asp-
Met-Gln-Asp (DMQD) tetrapeptide sequences whereas
caspase-6 recognizes the Val-Glu-Ile-Asp (VEID)
tetrapeptide sequence for cleavage after the aspartate
residue on the target proteins [30–32].
At present, there are two relatively well-characterized
cell death pathways that result in the activation of
the downstream executioner caspase-3. One is receptor-
mediated [34] and the other is mitochondrial-dependent.
The receptor-dependent pathway is initiated by activa-
tion of cell death receptors [Fas and tumor necrosis
actor-a (TNF-a) leading to activation of procaspase-
8, which, in turn, cleaves and activates procaspases-3.
The mitochondrial-dependent pathway is triggered by
cytochrome c release from the mitochondria. In 1996, Liu
et al [35] reported the surprising observation that holocy-
tochrome c (but not apocytochrome c) is required for the
activation of caspase-3 in a cell-free system. Cytochrome
c, once present in the cytosol, drives the assembly
of a high-molecular-weight caspase-activating complex
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termed the “apoptosome.” Cytochrome c binds to
Apaf-1, within its C-terminal region rich in Trp-Asp
(WD) motifs. Initially believed to be required only tran-
siently for caspase-9 activation, the Apaf-1/caspase-9
complex is now thought to actually represent the true ac-
tive form of caspase-9. Thus, Apaf-1 must be viewed not
simply as a caspase-9 activator, but rather as an essen-
tial regulatory subunit of a caspase-9 holoenzyme. This
holoenzyme, often referred to as the apoptosome, is a
very large complex that might well contain several addi-
tional proteins [28].
A new protein with the dual name Smac/DIABLO is
also released from the mitochondria and promotes cas-
pase activation by associating with the apoptosome and
inhibiting inhibitor of apoptosis protein (IAP) [36]. Pen-
ninger and Kroemer [37] have described a mitochondrial
protein named apoptosis-inducing factor (AIF) that in-
duces apoptosis independently of caspases. Recently, an-
other mitochcondrial factor translocating to the nucleus
has been isolated: endonuclease G (Endo G). Once lib-
erated into the cytosol, Endo G translocates toward the
nucleus where it generates oligonucleosomal DNA frag-
mentation even in the presence of caspase inhibitors.
Subsequent studies have demonstrated that Endo G cat-
alyzes both high-molecular-weight DNA cleavage and
oligonucleosomal DNA breakdown in a sequential fash-
ion. Moreover, Endo G cooperates with exonuclease and
DNase I to facilitate DNA processing [26].
Upon induction of apoptosis, mitochondria release sev-
eral potentially lethal proteins that either participate
in caspase activation (cytochrome c, Smac/DIABLO,
HtrA2) and/or can induce cell death in a caspase-
independent fashion (AIF, Endo G, HtrA2). At present,
it is difficult to weight the relative contribution of each of
these factors to apoptosis.
Caspases in hypoxia/reoxygenation injury to renal
tubular epithelial cells and in ischemic ARF
There is increasing evidence for the role of caspases
in hypoxic renal tubular cell injury. In our previous stud-
ies, we have demonstrated that chemical hypoxia with
antimycin A results in increased caspase activity that
precedes DNA damage and cell death. The caspase in-
hibitors prevent hypoxia-induced DNA fragmentation as
determined by agarose gel electrophoresis and by in situ
labeling of cell nuclei by TUNEL method [38]. Expo-
sure of hypoxia to freshly isolated renal tubular epithe-
lial cells result in caspase activation, cell membrane dam-
age and necrotic cell death. The pan-caspase inhibitor
attenuates the hypoxia-induced increase in caspase ac-
tivity in renal tubular epithelial cells and provides pro-
tection against hypoxia-induced cell membrane damage,
as determined by lactate dehydrogenase (LDH) release
[39]. Partial adenosine triphosphate (ATP) depletion of
Madin-Darby canine kidney (MDCK) cells by antimycin
A was also shown to result in apoptosis with marked
increase in activation of caspase-8 and the caspase in-
hibitors provide marked protection against antimycin A–
induced cell death [40].
We have shown differential regulation of caspases in
kidneys subjected to I/R injury [41]. In addition, the
proforms of caspase-1 and caspase-3 were cleaved to
their active forms during reperfusion indicating activa-
tion of these enzymes [41]. Caspase-3 activity was signifi-
cantly increased in the rat and murine models of renal
I/R injury [42]. The administration of pan-caspase in-
hibitor Z-VAD-FMK at the time of reperfusion sig-
nificantly prevented caspase-1 and caspase-3 activities
and provided marked protection against ischemic ARF
[43], consistent with the recent studies performed on
ischemic injury to gerbil forebrain and rat brain. The spe-
cific role of proinflammatory caspase-1 has also been ex-
amined in ischemic ARF. Caspase-1 is involved in the
proteolytic cleavage of the precursor forms of proinflam-
matory cytokines interleukin (IL)-1b and IL-18 that re-
sult in the formation of active forms of mature cytokines.
Since caspase-1 mediated formation of active IL-1b [44]
and IL-18 [45] is associated with inflammation in renal
I/R, caspase-1 may play an important role in I/R injury.
Thus far, two recent studies have investigated the role of
caspase-1 in I/R injury using caspase-1−/− mice but the re-
sults have remained inconsistent. One study reported that
caspase-1−/−mice provided significant protection against
I/R as reflected by renal function and renal histology
[46] while the other study demonstrated that caspase-
1−/−mice did not provide protection against I/R as re-
vealed by renal function with no change in blood urea
nitrogen and serum creatinine [47]. Thus, more studies
are required to demonstrate the definitive contribution
of caspase-dependent and caspase-independent forma-
tion of inflammatory products for the induction of inflam-
mation and apoptosis in ischemic ARF. A recent study
has demonstrated that caspase-3 activation during I/R
injury may be involved in the down-regulation of cal-
pastatin, an inhibitor of calpain [42], indicating a role of
caspases for calpain activation during renal injury. A rat
model of I/R injury indicated that prolonged ischemia
induced proapoptotic mechanisms, including increases in
the Bax/Bcl-2 ratio, caspase-3 expression, poly[adenosine
diphosphate (ADP)-ribose] polymerase (PARP) cleav-
age, DNA fragmentation, and apoptotic cell number in
renal proximal and distal tubules [48].
Regulatory mechanisms
In living cells, mitochondrial changes are predomi-
nantly prevented by antiapoptotic members of the Bcl-2
family of proteins. Bcl-2 was first discovered as a proto-
oncogene in follicular B-cell lymphoma. Subsequently, it
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was identified as a mammalian homologue to the apopto-
sis repressor ced-9 in Caenorhabditis elegans. Since then,
at least 19 Bcl-2 family members have been identified in
mammalian cells, which possess at least one of four con-
served motifs known as Bcl-2 homology domains (BH1 to
BH4). The Bcl-2 family members can be subdivided into
three categories according to their function and struc-
ture: (1) antiapoptotic members, such as Bcl-2, Bcl-XL,
Bcl-2, Mcl-1, and A1 (Bfl-1); (2) proapoptotic molecules,
such as Bax, Bak, and Bok (Mtd); and (3) the BH3-only
proteins, Bid, Bad, and Bim (these are called BH3-only
proteins because of four Bcl-2 homology regions they
share only the third). Saikumar et al [49] have shown
that the activation of caspase-3 during hypoxia or ATP
depletion was accompanied by the translocation of Bcl-2
family member bax from the cytosol to the mitochondria
and the release of cytochrome c from the mitochondria to
the cytosol. In addition, transfecting the cells with Bcl-2
provided protection against hypoxia-induced injury.
Recent studies from several laboratories have recog-
nized phosphatidylinositol 3′ (PI-3) kinase/Akt phospho-
rylation as one of the signaling pathways that blocks
apoptosis and promotes cell survival in response to di-
verse apoptotic stimuli in different cell types [50–53]. Akt
(also known as protein kinase B) was originally identified
as the cellular homologue of the transforming oncogene
of the AKT8 retrovirus [54, 55]. Akt is a serine/threonine
kinase, which is one of the downstream targets of PI-3
kinase [50, 51] which phosphorylates Akt and activates
it. Several pathways downstream of PI-3/Akt phosphory-
lation have been proposed for cell survival [50, 51]. One
of the well-studied molecules that mediate cell survival
by Akt phosphorylation is the proapoptotic Bcl-2 fam-
ily member Bad. Bad has the ability to directly interact
and bind to antiapoptotic Bcl-2 and Bcl-XL and blocks
their survival function [53, 56–58]. Phosphorylated Akt
can directly phosphorylate Bad both in vitro and in vivo
[52, 53, 59] and may render Bad incapable of binding
to Bcl-XL and restore the antiapoptotic function of Bcl-
2 [50, 58]. Sequestering phosphorylated Bad by 14-3-3
proteins [53, 56] may also participate in the Akt sur-
vival pathway by making it unavailable to bind to Bcl-
2 or prevent it from damaging the mitochondria. Many
studies have provided evidence that Bcl-2 family mem-
bers regulate activation of caspases through control of
cytochrome c release from the mitochondria [58, 60] and
by directly binding to Apaf 1, thus preventing the activa-
tion of procaspase-9 and subsequently caspase-3 [61]. We
have presented evidence that PI-3 kinase–mediated Akt
phosphorylation is associated with Bad phosphorylation
and suppression of caspase-9 and caspase-3 activation in
cisplatin-induced [62] injury to renal tubular epithelial
cells. Our studies show that wortmannin and LY294002,
inhibitors of PI-3 kinase, block cisplatin-induced phos-
phorylation of both Akt and Bad and enhance activa-
tion of caspase-9 and caspase-3 [62]. On the other hand,
these inhibitors have no effect on the activation of proin-
flammatory caspase-1 and receptor-dependent initiator
caspase-8. Similar results on activation of caspase-3 and
caspase-9 were obtained on inhibition of PI-3 kinase in
hypoxia-induced injury to renal tubular epithelial cells.
A recent study has shown that Akt can also phosphory-
late human caspase-9, resulting in reduction of caspase-
9 activity [63]. Based on these studies, the inhibition
of Akt phosphorylation as well as Bad phosphorylation
by wortmannin and LY294002 in hypoxia or cisplatin-
induced injury may contribute to enhanced activation
of mitochondrial-dependent caspase-3 and caspase-9, but
not receptor-mediated activation of caspase-8 or proin-
flammatory caspase-1 [36].
CONCLUSION
The study of cell death has emerged as one of most in-
vestigated areas of research in life sciences. This has led to
a better understanding of the complexity of the cell death
process, including the intricacies of the various paths with
their complex interweaving and redundancies. There has
been little progress in preventing and treating ARF. A
better understanding for the mechanisms together with
carefully defining the various populations at risk for ARF
and using specific (perhaps multiple) tools for subsets of
patients rather than a gunshot approach may allow us to
prevent and treat ARF.
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Apoptosis in ischemic renal injury: Roles of GTP depletion and
p53.
Apoptosis is increasingly recognized as a major mode of cell
demise after ischemic injury to the kidney. The mediators of
apoptotic cell death are many and include changes in intra-
cellular pH, calcium, free radicals, ceramide, and adenosine
triphosphate (ATP) depletion. Recently, we identified guano-
sine triphosphate (GTP) depletion as an independent trigger
for apoptotic death after chemical anoxia in vitro. We further
demonstrated that GTP salvage with guanosine inhibits tubu-
lar cell apoptosis after ischemic injury in vivo. This inhibition
of apoptosis was accompanied by a significant protective effect
on renal function. We also showed that p53 is the mediator of
apoptosis in the setting of GTP depletion and ischemic injury.
Indeed, salvage of GTP with guanosine prevented the ischemia-
induced increase in p53 protein. Further, pifithrin-alpha, a
potent and specific inhibitor of p53, inhibited apoptosis and
protected renal function with a profile similar to that seen with
guanosine. Finally, the protective effects of pifithrin-alpha in-
volved both down-regulation of the transcriptional activation
of Bax and a direct inhibition of p53 translocation to mito-
chondria. We propose that GTP depletion and activation of
p53 are major inducers of apoptotic cell death after ischemic
renal injury. In this setting, guanosine and pifithrin-alpha are
potent inhibitors of apoptosis and are thus potentially useful in
preventing and ameliorating functional injury to the ischemic
kidney.
Ischemic renal injury has been traditionally associated
with tubular cell necrosis along with obstructive cast for-
mation, disruption of architecture, and a significant in-
flammatory response. Early attempts at preventing and
treating ischemic injury were primarily targeted at this
“necrotic” phenotype and generally met with moder-
ate success, at least in animal models of this disease.
Key words: guanine nucleotides, ischemia, p53, mitochondria, kidney,
apoptosis.
Only recently did apoptosis emerge as a significant mode
of cell death during ischemic renal injury [1, 2]. While
the contribution of apoptotic cell death to functional
deterioration of the organ is obvious in conditions like
myocardial infarction and stroke, it is less clear how
apoptotic dropout of tubular cells can impact glomeru-
lar filtration rate (GFR). Nevertheless, recent reports
have demonstrated that interference with the apoptotic
program does translate into a protective effect on renal
function [3–5]. This opened new avenues for poten-
tial therapeutic modalities targeting various steps of the
highly organized and fairly well-understood process of
apoptotic cell demise.
THE MEDIATORS OF CELL DEATH DURING
ISCHEMIC RENAL INJURY
The apoptotic program itself has been extensively char-
acterized and is fairly well preserved among cell types,
tissues, and species. However, the primary triggers of this
program are many and do show organ, species, and in-
sult specificities. In particular, ischemia/reperfusion (I/R)
injury is accompanied by a myriad of changes in sig-
naling molecules and metabolic effectors that can, in-
dependently or in concert, trigger cell death in vari-
ous forms. These include changes in intracellular pH,
calcium, ceramide, free radicals, hypoxia and adenosine
triphosphate (ATP) depletion. While all of these factors
are grossly deranged during abrupt necrotic cell death,
they can also be specific effectors of apoptotic death un-
der certain circumstances. The current literature suggests
that the mode of cell death that results from ischemic
injury depends in part on the severity of the primary
alterations in these factors. For example, severe ATP
depletion invariably causes necrosis that is likely related
to cessation of all vital enzymatic functions and Na/K
